Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis

Prevalence and Clinical Characteristics of Psoriatic Arthritis in Japan

(2015) Y. Ohara et al.   JOURNAL OF RHEUMATOLOGY

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database

(2015) K. Kubota et al.   BMJ Open

Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World

(2014) Fausto Salaffi et al.   Biomed Research International

IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants

(2014) Andrea Saggini et al.   Journal of Immunology Research

Serum Interleukin 6 Before and After Therapy with Tocilizumab Is a Principal Biomarker in Patients with Rheumatoid Arthritis

(2013) K. Shimamoto et al.   JOURNAL OF RHEUMATOLOGY

Serum interleukin‐6 levels in response to methotrexate treatment in psoriatic patients

(2012) Tamilselvi Elango et al.   CLINICA CHIMICA ACTA

Cytokine-Based Therapy in Psoriasis

(2012) Anupam Mitra et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

The Path Forward to Biomarker Discovery in Psoriatic Disease: A Report from the GRAPPA 2010 Annual Meeting

(2012) D. D. GLADMAN et al.   JOURNAL OF RHEUMATOLOGY

IL-6: Regulator of Treg/Th17 balance

(2010) Akihiro Kimura et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

(2010) Batya B. Davidovici et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells

(2009) W. A. Goodman et al.   JOURNAL OF IMMUNOLOGY

The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

(2009) Antonella Di Cesare et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Psoriasis

(2009) Frank O. Nestle et al.   NEW ENGLAND JOURNAL OF MEDICINE